Release Date: 29/08/14 17:11 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 1.13MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%